Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Safety of CFTR modulator treatments during pregnancy: what global safety reports tell us

Safety of CFTR modulator treatments during pregnancy: what global safety reports tell us

Resource Type

CF Research News

Authors

Nazanin Abolhassani, Kim Dao, Roberta Noseda, Francesca Bedussi, Alessandro Ceschi, Alice Panchaud, Ursula Winterfeld

References

2026 Jan;25(1):21-27.  doi: 10.1016/j.jcf.2025.11.007. Epub 2025 Nov 20.

Document

File JCF-D-25-00410R1_FINAL_Winterfeld_12122026.docx [1]

Keywords

CFTR modulators [2]
Disproportionality [3]
Pharmacovigilance [4]
pregnancy [5]
VigiBase [6]

Date

Tuesday, January 20, 2026

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [7]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/safety-cftr-modulator-treatments-during-pregnancy-what-global

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-25-00410R1_FINAL_Winterfeld_12122026.docx [2] https://www.ecfs.eu/research-article-keywords/cftr-modulators [3] https://www.ecfs.eu/research-article-keywords/disproportionality [4] https://www.ecfs.eu/research-article-keywords/pharmacovigilance [5] https://www.ecfs.eu/research-article-keywords/pregnancy [6] https://www.ecfs.eu/research-article-keywords/vigibase [7] https://www.ecfs.eu/resource-guideline-type/other-guidelines